drugset / Trial / NCT07446881

A Phase 1 Study, to Evaluate the Effect of ADV7103 on Gastric pH Under Fed and Fasting Conditions in Adult Healthy Participants.

NCT07446881 ↗

Phase 1 Completed 12 enrolled Advicenne Pharma
NaSingle-groupOpen-labelOther

Summary

This was a Phase 1, single-center, randomized, controlled, Latin-square, open-label study to evaluate the effect of ADV7103 on the gastric pH, after administering a single oral dose of ADV7103 in healthy adult participants under fasting and fed conditions

Timeline

Start
2025-02-25
Primary completion
2025-03-15
Completion
2025-03-15

Drugs

EvaluationDrugModalityDoseRoute
Subject ADV7103 Unknown — Oral